| CSK |
CSK: Tyrosine-protein kinase CSK |
CENTB2 |
CENTB2, KIAA0041: Centaurin-beta 2 |
0.4 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
ARHGEF6 |
ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 |
0.4 |
Evidence |
|
| CSK |
CSK: Tyrosine-protein kinase CSK |
IRAK1 |
IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 |
0.4 |
Evidence |
|
| MLH1 |
MLH1, COCA2: DNA mismatch repair protein Mlh1 |
ATR |
ATR, FRP1: Serine/threonine-protein kinase ATR |
0.4 |
Evidence |
|
| RPL3 |
RPL3, OK/SW-cl.32: 60S ribosomal protein L3 |
YBX1 |
YBX1, NSEP1, YB1: Nuclease sensitive element-binding protein 1 |
0.4 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
TOPBP1 |
TOPBP1, KIAA0259: DNA topoisomerase 2-binding protein 1 |
0.4 |
Evidence |
|
| BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
SMC1L1 |
SMC1A, DXS423E, KIAA0178, SB1.8, SMC1, SMC1L1: Structural maintenance of chromos |
0.4 |
Evidence |
O
|
| TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
STK24 |
STK24, MST3, STK3: Serine/threonine-protein kinase 24 |
0.4 |
Evidence |
|
| TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
0.4 |
Evidence |
|
| TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
ILK |
ILK, ILK1, ILK2: Integrin-linked protein kinase |
0.4 |
Evidence |
|
| TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
RAP1B |
RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor |
0.4 |
Evidence |
|
| TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
SYK |
SYK: Tyrosine-protein kinase SYK |
0.4 |
Evidence |
|
| TAGLN2 |
TAGLN2, RP11-48O20.1-003, hCG_39730: TAGLN2 protein |
CSK |
CSK: Tyrosine-protein kinase CSK |
0.4 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
PSMB7 |
PSMB7: Proteasome subunit beta type-7 precursor |
0.4 |
Evidence |
|
| MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
CSK |
CSK: Tyrosine-protein kinase CSK |
0.4 |
Evidence |
|
| COPB2 |
COPB2: Coatomer subunit beta' |
SNRPD3 |
SNRPD3: Small nuclear ribonucleoprotein Sm D3 |
0.4 |
Evidence |
|
| GTF2F1 |
GTF2F1, RAP74: Transcription initiation factor IIF subunit alpha |
BRD3 |
BRD3, KIAA0043, RING3L: Bromodomain-containing protein 3 |
0.4 |
Evidence |
|
| GTF2F1 |
GTF2F1, RAP74: Transcription initiation factor IIF subunit alpha |
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
0.4 |
Evidence |
|
| MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
WRN |
WRN, RECQ3, RECQL2: Werner syndrome ATP-dependent helicase |
0.4 |
Evidence |
|
| MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
YBX1 |
YBX1, NSEP1, YB1: Nuclease sensitive element-binding protein 1 |
0.4 |
Evidence |
|
| MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
YARS |
YARS: Tyrosyl-tRNA synthetase, cytoplasmic |
0.4 |
Evidence |
|
| MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
BLM |
BLM, RECQ2, RECQL3: Bloom syndrome protein |
0.4 |
Evidence |
|
| MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
GTF2F1 |
GTF2F1, RAP74: Transcription initiation factor IIF subunit alpha |
0.4 |
Evidence |
|
| AKT1 |
AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase |
SNX17 |
SNX17, KIAA0064: Sorting nexin-17 |
0.4 |
Evidence |
|
| PDIA3 |
PDIA3, ERP57, ERP60, GRP58: Protein disulfide-isomerase A3 precursor |
TXNDC |
TXNDC1, TMX, PSEC0085, TXNDC, UNQ235/PRO268: Thioredoxin domain-containing prote |
0.4 |
Evidence |
|